© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 3, 229-230,
February 6, 2002
© 2002 Oxford University Press
CORRESPONDENCE |
Re: Debate on the Link Between SV40 and Human Cancer Continues
Affiliations of authors: M. Carbone, Cardinal Bernardin Cancer Center, Loyola University Medical School Chicago, Maywood IL; H. I. Pass, Karmanos Cancer Institute, Wayne State University, Detroit, MI.
Correspondence to: Michele Carbone, M.D., Ph.D., Cardinal Bernardin Cancer Center Room 205, Loyola University Medical School Chicago, 2160 S. First Ave., Rm. 205, Maywood, IL 60153 (e-mail: mcarbon@orion.it.luc.edu).
Overall, Nancy Nelson's news article about simian virus 40 (SV40) and human tumors (1) was well balanced. We would like to make some additional comments. (More information can be found in the February 2001 issue of Seminars in Cancer Biology.)
First, the statement in the sidebar that SV40 causes "abnormalities" in human cells underestimates the extent of damage. Human cells infected by SV40 in vitro develop extensive genetic
REFERENCES
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. C. Kennedy, M. H. Shearer, A. M. Watts, and R. K. Bright CD4+ T Lymphocytes Play a Critical Role in Antibody Production and Tumor Immunity against Simian Virus 40 Large Tumor Antigen Cancer Res., March 1, 2003; 63(5): 1040 - 1045. [Abstract] [Full Text] [PDF] |
||||
